DCGI gives nod for use of Itolizumab for Covid

New Delhi, Jul 11 :Drugs Controller General of India (DCGI) has granted Restricted Emergency Use authorisation for Itolizumab (rDNA origin), a monoclonal antibody which was already approved for severe chronic plaque psoriasis, based on…